ADC Therapeutics SA (NYSE:ADCT) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Eugenia Litz - Vice President of Investor Relations and Corporate Communications Ameet Mallik - Chief Executive Officer Kristen Herrington-Smith - Chief Commercial Officer Mohamed Zaki - Chief Medical Officer Pepe Carmona - Chief Financial Officer Conference Call Participants Kelly Shi - Jefferies Naureen Quibria - Capital One Securities Michael Riad - Morgan Stanley Brian Chan - JPMorgan Operator ...